Bulletin 120 | Matt Fletcher, John Roberts, Dan Ryan, Adele Groyer
COVID-19 is still one of the hottest topics for scientific papers and articles. The COVID‑19 Actuaries Response Group provides a regular fortnightly update with a summary of the key papers and analyses that we’ve looked at recently.
In this issue, we look at:
- Fourth vaccine approved in the UK – the single-dose Janssen vaccine
- Impressive trial results for Pfizer on 12-15 year olds
- Good progress with vaccine take-up in the UK
- Prevalence of the Indian variant
- Mechanism for the blood clotting seen (rarely) with adenovirus vaccines
- ONS data on antibodies and infectivity
- R in the England above 1 in London and the North-West
- New ECDC variants dashboard